| Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL (NCT04855253) | Masonic Cancer Center, University of Minnesota | 2021-06-09 |
| Comparison Between Adjuvants Added to Bupivacaine in Adductor Canal Block (NCT04892420) | Ain Shams University | 2021-06-09 |
| Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT04913337) | NGM Biopharmaceuticals, Inc | 2021-06-09 |
| Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment (NCT04706598) | Fudan University | 2021-06-09 |
| Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma (NCT04901702) | St. Jude Children's Research Hospital | 2021-06-09 |
| No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer (NCT04864067) | Servicio de Salud Metropolitano Sur Oriente | 2021-06-09 |
| Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) (NCT04558866) | Latin American Cooperative Oncology Group | 2021-06-09 |
| The Re-Prosper HF Study (NCT04551222) | VA Office of Research and Development | 2021-06-09 |
| Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis (NCT04840485) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-06-09 |
| To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (NCT04843319) | Veru Inc. | 2021-06-09 |
| A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) (NCT04867616) | UCB Biopharma SRL | 2021-06-09 |
| Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19 (NCT04902183) | Athens Medical Society | 2021-06-09 |
| A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer (NCT04676516) | Ottawa Hospital Research Institute | 2021-06-08 |
| To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants (NCT04914377) | Novatek Pharmaceuticals | 2021-06-08 |
| A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction (NCT04836182) | Ionis Pharmaceuticals, Inc. | 2021-06-08 |
| Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases (NCT04647916) | SWOG Cancer Research Network | 2021-06-08 |
| Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance (NCT04614558) | Columbia University | 2021-06-08 |
| Bilateral Essential Tremor Treatment With Gamma Knife (NCT04748640) | Université de Sherbrooke | 2021-06-08 |
| Lenalidomide and Dexamethasone for Rosai-Dorfman Disease (NCT04924647) | Peking Union Medical College Hospital | 2021-06-08 |
| Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) (NCT04464980) | NYU Langone Health | 2021-06-08 |
| Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis (NCT04943653) | Seoul St. Mary's Hospital | 2021-06-08 |
| A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects (NCT04904913) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-06-08 |
| A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas (NCT04917861) | ModernaTX, Inc. | 2021-06-07 |
| A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer (NCT04837508) | Shanghai Miracogen Inc. | 2021-06-07 |
| Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma (NCT04589663) | Novartis Pharmaceuticals | 2021-06-07 |
| KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma (NCT04601610) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2021-06-07 |
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors (NCT04493333) | University of Arkansas | 2021-06-07 |
| Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia (NCT04867343) | Jiangsu HengRui Medicine Co., Ltd. | 2021-06-07 |
| A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68) (NCT04875195) | Merck Sharp & Dohme LLC | 2021-06-07 |
| A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (NCT04709276) | Andrew J. Armstrong, MD | 2021-06-07 |
| AMI-DC in Patients With Anterior Wall Myocardial Infarction (NCT05554484) | The Catholic University of Korea | 2021-06-07 |
| High Frequency Impulse Therapy for Neuropathic Pain in NMOSD (NCT04614454) | Massachusetts General Hospital | 2021-06-07 |
| Open-Label Study of Setmelanotide in Hypothalamic Obesity (NCT04725240) | Rhythm Pharmaceuticals, Inc. | 2021-06-07 |
| Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis (NCT04879628) | Sanofi | 2021-06-07 |
| Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma (NCT04840069) | St. Joseph's Hospital and Medical Center, Phoenix | 2021-06-07 |
| The Study of CM310 in Patients With Atopic Dermatitis (NCT04893707) | Keymed Biosciences Co.Ltd | 2021-06-07 |
| Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19. (NCT04952805) | Toscana Life Sciences Sviluppo s.r.l. | 2021-06-06 |
| A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation (NCT06365437) | ITB-Med LLC | 2021-06-06 |
| TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies (NCT04915482) | Institute of Hematology & Blood Diseases Hospital, China | 2021-06-06 |
| Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia (NCT04896528) | Peking Union Medical College Hospital | 2021-06-06 |
| Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (NCT05000450) | Allogene Therapeutics | 2021-06-06 |
| Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases (NCT04887298) | Moleculin Biotech, Inc. | 2021-06-05 |
| 4-aminopyridine Treatment for Nerve Injury (NCT03701581) | John Elfar | 2021-06-05 |
| A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy (NCT04159493) | Aspen USA Inc | 2021-06-05 |
| A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT04808570) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-05 |
| Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer (NCT04927910) | The Hong Kong Polytechnic University | 2021-06-05 |
| Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) (NCT04929483) | 89bio, Inc. | 2021-06-04 |
| Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD (NCT04889664) | Icahn School of Medicine at Mount Sinai | 2021-06-04 |
| Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma (NCT04701918) | Massachusetts General Hospital | 2021-06-04 |
| Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab (NCT04887831) | G1 Therapeutics, Inc. | 2021-06-04 |
| Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial (NCT04147624) | University of Miami | 2021-06-04 |
| 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV) (NCT04922151) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2021-06-04 |
| Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) (NCT04352400) | University Hospital Padova | 2021-06-04 |
| Dose-response of Cannabis and Driving (NCT03656029) | Centre for Addiction and Mental Health | 2021-06-04 |
| Quercetin in Coronary Artery By-pass Surgery (NCT04907253) | Montreal Heart Institute | 2021-06-04 |
| Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL (NCT04938232) | Dana-Farber Cancer Institute | 2021-06-04 |
| Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC (NCT04779554) | Prakash Pandalai | 2021-06-04 |
| SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma (NCT04803877) | Sarcoma Alliance for Research through Collaboration | 2021-06-04 |
| An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) (NCT04563338) | University Health Network, Toronto | 2021-06-04 |
| Study of Efficacy of BZ019 in Large B-cell Lymphoma (NCT05472610) | Shanghai Mengchao Cancer Hospital | 2021-06-04 |
| Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) (NCT04703192) | Daiichi Sankyo | 2021-06-03 |
| A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations (NCT06132932) | Shanghai Jiatan Pharmatech Co., Ltd | 2021-06-03 |
| Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE (NCT04643067) | Kangpu Biopharmaceuticals, Ltd. | 2021-06-03 |
| Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma (NCT04747145) | Medical College of Wisconsin | 2021-06-03 |
| EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial (NCT04891133) | Oslo University Hospital | 2021-06-03 |
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (NCT04730349) | Bristol-Myers Squibb | 2021-06-03 |
| Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer (NCT04717531) | The First Affiliated Hospital with Nanjing Medical University | 2021-06-03 |
| To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL) (NCT06698484) | National University of Malaysia | 2021-06-03 |
| Image - Navigated Resection of Lung Nodules (NCT04702165) | Navigation Sciences, Inc. | 2021-06-03 |
| Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 (NCT04748705) | Virios Therapeutics, Inc. | 2021-06-03 |
| A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 (NCT05086666) | Abbisko Therapeutics Co, Ltd | 2021-06-03 |
| Dopaminergic Therapy for Frontotemporal Dementia Patients (NCT04937452) | I.R.C.C.S. Fondazione Santa Lucia | 2021-06-03 |
| A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS) (NCT04962503) | Clinuvel Pharmaceuticals Limited | 2021-06-03 |
| Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects (NCT04861584) | Zhujiang Hospital | 2021-06-03 |
| Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects (NCT04909723) | Novome Biotechnologies Inc | 2021-06-02 |
| Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation (NCT04918953) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-06-02 |
| ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL (NCT04603183) | MedSIR | 2021-06-02 |
| Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn (NCT04898114) | Sohag University | 2021-06-02 |
| Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients (NCT05172817) | Institute for Developing Science and Health Initiatives, Bangladesh | 2021-06-02 |
| A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis (NCT05467995) | Akeso | 2021-06-02 |
| Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma (NCT04558931) | Karolinska Institutet | 2021-06-02 |
| Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC (NCT04952168) | Yuan Chen | 2021-06-02 |
| Benralizumab Initiated During Severe Asthma Attack (NCT04617171) | Singapore General Hospital | 2021-06-02 |
| Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study (NCT04936113) | Forte Biosciences, Inc. | 2021-06-02 |
| Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma (NCT04680468) | University of Pennsylvania | 2021-06-02 |
| Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA (NCT04319783) | Trans Tasman Radiation Oncology Group | 2021-06-02 |
| Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer (NCT04835896) | Yonsei University | 2021-06-02 |
| Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients (NCT05447013) | George Papanicolaou Hospital | 2021-06-02 |
| Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) (NCT04622007) | Effector Therapeutics | 2021-06-02 |
| A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy (NCT04873752) | Rohto Pharmaceutical Co., Ltd. | 2021-06-02 |
| Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria (NCT04944966) | Ifakara Health Institute | 2021-06-02 |
| Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW (NCT05359874) | Technical University of Munich | 2021-06-01 |
| Combination of the Immune Modulator Dimethyl Fumarate With Intraarterial Treatment in Acute Ischemic Stroke (NCT04891497) | Xuanwu Hospital, Beijing | 2021-06-01 |
| Adjunctive Celecoxib in Childhood-onset OCD Study (NCT04673578) | University of British Columbia | 2021-06-01 |
| Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC. (NCT04911517) | Beijing Friendship Hospital | 2021-06-01 |
| Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer (NCT04840758) | The First Affiliated Hospital of Xiamen University | 2021-06-01 |
| Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer (NCT04635059) | Medical College of Wisconsin | 2021-06-01 |
| Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma (NCT04674527) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-06-01 |
| Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients (NCT04502680) | The First Affiliated Hospital with Nanjing Medical University | 2021-06-01 |
| Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage (NCT04890379) | Xuanwu Hospital, Beijing | 2021-06-01 |